Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plantain seed decoction is a Traditional Chinese Medicine (TCM) aqueous preparation derived from the seeds of *Plantago asiatica* L. (known as Che Qian Zi). It has been specifically developed and clinically investigated by researchers at Shuguang Hospital affiliated to Shanghai University of TCM for the treatment of metabolic syndrome and its components, including type 2 diabetes mellitus, hypertension, and dyslipidemia. The decoction contains a variety of bioactive compounds, including phenylethanoid glycosides (such as acteoside and plantamajoside), iridoids (such as geniposidic acid), and flavonoids. Its therapeutic mechanism involves the regulation of glucose and lipid metabolism, improvement of insulin sensitivity, and potential diuretic effects that contribute to blood pressure management. Clinical studies conducted at Shuguang Hospital have evaluated its efficacy in improving glycemic control, lipid profiles, and waist circumference in patients with metabolic disturbances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on plantain seed decoction.